Abstract
Muscle relaxants are used in almost two-thirds of anaesthesias. In case they are used, subsequent adequate reversal of neuromuscular blockade is crucial, as post- operative residual curarisation increases postoperative morbidity.
For neuromuscular blockade reversal sugammadex can be used which has a very good efficacy and favourable safety profile; the greatest benefit from its use has been shown in patients aged > 65 years, with ASA score >= III or body mass index > 35, and in patients undergoing laparoscopic surgery. The administration of sugammadex prevents the development of postoperative complications and increases safety of the patients.
Currently, sugammadex can be considered as a standard of care and should be offered to a much wider range of patients than has been the case to date.